Neoadjuvant Treatment in Pancreatic Cancer
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference110 articles.
1. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med.,2012
2. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials;Oppedijk;J Clin Oncol.,2014
3. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol.,2015
4. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med.,2006
5. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial;Al-Batran;Lancet Oncol.,2016
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival?;Surgery;2024-03
2. Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resection;Surgical Oncology Insight;2024-02
3. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer;Redox Biology;2024-02
4. Treatment of pancreatic adenocarcinoma in relation to survival in the U.S. Military Health System;Cancer Epidemiology;2024-02
5. Microbiome as a biomarker and therapeutic target in pancreatic cancer;BMC Microbiology;2024-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3